Lyell Immunopharma, Inc.（LYEL）内部人交易：高管与董事近期交易
过去 18 个月，共有 21 位内部人为 Lyell Immunopharma, Inc.（LYEL）报告了 67 笔 Form 4 交易（最近一笔 2026-09-10）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-10 | Shook David | Chief Medical Officer | 卖出 | 500 | $6,350 |
| 2026-08-25 | Seely Lynn | President and CEO | 卖出 | 9,589 | $149,013 |
| 2026-08-25 | Hill Stephen J. | Chief Operating Officer | 卖出 | 989 | $15,369 |
| 2026-08-25 | Lee Gary K. | Chief Scientific Officer | 卖出 | 1,457 | $22,642 |
| 2026-08-11 | Bulis Veronica Sanchez | VP, Corporate Controller | 卖出 | 621 | $8,905 |
| 2026-08-11 | Hill Stephen J. | Chief Operating Officer | 卖出 | 89 | $1,276 |
| 2026-08-11 | Lee Gary K. | Chief Scientific Officer | 卖出 | 131 | $1,879 |
| 2026-08-11 | Seely Lynn | President and CEO | 卖出 | 390 | $5,593 |
| 2026-07-27 | Innovative Cellular Therapeutics Holdings Ltd | 10% 以上股东 | 卖出 | 38,500 | $0 |
| 2026-07-27 | Innovative Cellular Therapeutics Holdings Ltd | 10% 以上股东 | 卖出 | 44,000 | $0 |
| 2026-07-20 | Innovative Cellular Therapeutics Holdings Ltd | 10% 以上股东 | 卖出 | 10 | $137 |
| 2026-07-17 | Innovative Cellular Therapeutics Holdings Ltd | 10% 以上股东 | 卖出 | 10 | $137 |
| 2026-07-01 | Innovative Cellular Therapeutics Holdings Ltd | 10% 以上股东 | 卖出 | 76,000 | $0 |
| 2026-06-18 | Innovative Cellular Therapeutics Holdings Ltd | 10% 以上股东 | 卖出 | 66,500 | $0 |
| 2026-06-15 | Bulis Veronica Sanchez | VP, Corporate Controller | 卖出 | 217 | $4,103 |
| 2026-06-15 | Hill Stephen J. | Chief Operating Officer | 卖出 | 89 | $1,684 |
| 2026-06-15 | Lee Gary K. | Chief Scientific Officer | 卖出 | 130 | $2,460 |
| 2026-06-15 | Seely Lynn | President and CEO | 卖出 | 388 | $7,337 |
| 2026-06-11 | Shook David | Chief Medical Officer | 卖出 | 1,977 | $24,989 |
| 2026-03-09 | BERNS PAUL L | 10% 以上股东 | 买入 | 488,090 | $12.5M |
| 2026-03-09 | Burow Kristina | 10% 以上股东 | 买入 | 488,090 | $12.5M |
| 2026-03-09 | CRANDELL KEITH | 10% 以上股东 | 买入 | 488,090 | $12.5M |
| 2026-03-09 | NELSEN ROBERT | 10% 以上股东 | 买入 | 488,090 | $12.5M |
| 2026-03-09 | BYBEE CLINTON | 10% 以上股东 | 买入 | 488,090 | $12.5M |
| 2026-03-09 | GILLIS STEVEN | 10% 以上股东 | 买入 | 488,090 | $12.5M |
来源：SEC Form 4 申报文件 · 截至 2026-09-10